About Biotheranostics
Biotheranostics is a company based in San Diego (United States) founded in 2008 was acquired by Hologic in January 2021. Biotheranostics has raised $32 million across 1 funding round from investors including Hologic, MVM Partners and Canepa Healthcare. Biotheranostics operates in a competitive market with competitors including DermTech, Molbio Diagnostics, NeuMoDx, Kryptos Biotechnologies and PreludeDx, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biotheranostics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Biotheranostics
Unlock access to complete
Funding Insights of Biotheranostics
Biotheranostics has successfully raised a total of $32M through 1 strategic funding round. The most recent funding activity was a Series A round of $32 million completed in January 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biotheranostics
Biotheranostics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Hologic, MVM Partners and Canepa Healthcare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Investments are focused on tech and life sciences startups.
|
Locked | Locked | Locked | |
|
Private equity investments in healthcare companies are managed.
|
Locked | Locked | Locked |
Investor details for Biotheranostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biotheranostics
Investment portfolio details for Biotheranostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biotheranostics
Detailed financials for Biotheranostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biotheranostics Comparisons
Peer comparison for Biotheranostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biotheranostics
Biotheranostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermTech, Molbio Diagnostics, NeuMoDx, Kryptos Biotechnologies and PreludeDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| Locked | Locked | Locked |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| Locked | Locked | Locked |
Developer of a platform for low cost molecular testing
|
|
| Locked | Locked | Locked |
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
|
|
| Locked | Locked | Locked |
Risk assessment tests for early-stage breast cancer are provided.
|
|
| Locked | Locked | Locked |
Next-generation molecular detection kits for viral diseases are developed.
|
Detailed competitors of Biotheranostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biotheranostics
Complete news archive for Biotheranostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biotheranostics
Biotheranostics was founded in 2008 and raised its 1st funding round 8 years after it was founded.
Biotheranostics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Biotheranostics is a funded company, having raised a total of $32M across 1 funding round to date.
BioTheranostics was founded in 2008 and is based in San Diego, United States. Operations focus on the biotechnology sector, where proprietary molecular-based diagnostic, prognostic, and predictive tests are developed and commercialized for cancer treatment guidance. Key offerings include the Breast Cancer Index for decisions on extended endocrine therapy in estrogen receptor-positive breast cancer, and Cancer Type ID for molecular diagnosis and biomarker analysis in metastatic cases.
Biotheranostics's top competitors include DermTech, Molbio Diagnostics and NeuMoDx.
Biotheranostics has 4 investors. Key investors include Hologic, MVM Partners, Canepa Healthcare, and Health Quest Capital.